This site is intended for health professionals only
Wednesday 21 November 2018
Share |

Latest News

Galcanezumab approved for the prophylaxis of migraine in adults

Tuesday 20th November 2018

Eli Lilly and Company has announced that the European Commission (EC) has granted marketing authorisation for Emgality® (galcanezumab) for the prophylaxis of migraine in adults who have at least four migraine days per month.1


Galcanezumab is a humanised monoclonal antibody that binds to the calcitonin gene-related peptide (CGRP), which plays a role in migraine attacks, blocking its downstream function.1 Galcanezumab...

Mon, 19 Nov 2018
NHS trusts face staff shortage of more than 350,000 by 2030, think tanks warn
Thu, 15 Nov 2018
Matt Hancock made the comments during a five-hour cabinet meeting discussing the Brexit deal negotiated with the EU by Prime Minister Theresa May, according to The Times
Wed, 14 Nov 2018
My pharmacy story: Royal Pharmaceutical Society English Pharmacy Board chair Sandra Gidley
Fri, 9 Nov 2018
Diabetes prescriptions cost NHS over £1bn a year, data reveals
Thu, 8 Nov 2018
Vyxeos is an advanced liposomal formulation that delivers a synergistic molar ratio of daunorubicin and cytarabine
Thu, 8 Nov 2018
UK building ‘refrigeration capacity’ in case of Brexit drug shortages
Wed, 7 Nov 2018
Olarpip could provide effective treatment for brain tumours, charity reveals

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?


Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.



Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher